Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-28

Clinical Trial Update: A Study of Yiqi Yangyin Formula in the Treatment of Primary Sjogren's Syndrome [NA]

View source ↗

Summary

This clinical trial investigates Yiqi Yangyin Formula for treating Primary Sjögren's syndrome; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yiqi Yangyin Formula

Snippet

Sponsor: China-Japan Friendship Hospital | Conditions: Primary Sjögren's Syndrome (pSS) | NA | Status: NOT_YET_RECRUITING